Liu Y - Search Results

1

A novel fluorinated polyethyleneimine with microRNA-942-5p-sponges polyplex gene delivery system for non-small-cell lung cancer therapy.

Jin Y, Yu W, Zhang W, Wang C, Liu Y, Yuan WE, Feng Y. Jin Y, et al. Among authors: liu y. J Colloid Interface Sci. 2023 Oct 15;648:287-298. doi: 10.1016/j.jcis.2023.05.153. Epub 2023 May 29. J Colloid Interface Sci. 2023. PMID: 37301153

2

Immune Activities of Polycationic Vectors for Gene Delivery.

Zhao X, Li X, Zhao Y, Cheng Y, Yang Y, Fang Z, Xie Y, Liu Y, Chen Y, Ouyang Y, Yuan W. Zhao X, et al. Among authors: liu y. Front Pharmacol. 2017 Aug 4;8:510. doi: 10.3389/fphar.2017.00510. eCollection 2017. Front Pharmacol. 2017. PMID: 28824434 Free PMC article. Review.

3

Recent advances in small molecule based cancer immunotherapy.

Cheng B, Yuan WE, Su J, Liu Y, Chen J. Cheng B, et al. Among authors: liu y. Eur J Med Chem. 2018 Sep 5;157:582-598. doi: 10.1016/j.ejmech.2018.08.028. Epub 2018 Aug 13. Eur J Med Chem. 2018. PMID: 30125720 Review.

4

Tumor-Microenvironment- Responsive Size-Shrinkable Drug-Delivery Nanosystems for Deepened Penetration Into Tumors.

Cheng X, Li H, Ge X, Chen L, Liu Y, Mao W, Zhao B, Yuan WE. Cheng X, et al. Among authors: liu y. Front Mol Biosci. 2020 Nov 27;7:576420. doi: 10.3389/fmolb.2020.576420. eCollection 2020. Front Mol Biosci. 2020. PMID: 33330618 Free PMC article. Review.

5

Discovery of novel benzohydroxamate-based histone deacetylase 6 (HDAC6) inhibitors with the ability to potentiate anti-PD-L1 immunotherapy in melanoma.

Peng X, Yu Z, Surineni G, Deng B, Zhang M, Li C, Sun Z, Pan W, Liu Y, Liu S, Yu B, Chen J. Peng X, et al. Among authors: liu y, liu s. J Enzyme Inhib Med Chem. 2023 Dec;38(1):2201408. doi: 10.1080/14756366.2023.2201408. J Enzyme Inhib Med Chem. 2023. PMID: 37096557 Free PMC article.

6

Vitamin D and its analogs as anticancer and anti-inflammatory agents.

Chen J, Tang Z, Slominski AT, Li W, Żmijewski MA, Liu Y, Chen J. Chen J, et al. Among authors: liu y. Eur J Med Chem. 2020 Dec 1;207:112738. doi: 10.1016/j.ejmech.2020.112738. Epub 2020 Aug 15. Eur J Med Chem. 2020. PMID: 32829183 Review.

7

Design, synthesis and biological evaluation of benz-fused five-membered heterocyclic compounds as tubulin polymerization inhibitors with anticancer activities.

Komuraiah B, Ren Y, Xue M, Cheng B, Liu J, Liu Y, Chen J. Komuraiah B, et al. Among authors: liu j, liu y. Chem Biol Drug Des. 2021 May;97(5):1109-1116. doi: 10.1111/cbdd.13832. Epub 2021 Mar 11. Chem Biol Drug Des. 2021. PMID: 33638903

8

Discovery of Ibrutinib-based BTK PROTACs with in vivo anti-inflammatory efficacy by inhibiting NF-κB activation.

Huang J, Ma Z, Yang Z, He Z, Bao J, Peng X, Liu Y, Chen T, Cai S, Chen J, Zeng Z. Huang J, et al. Among authors: liu y. Eur J Med Chem. 2023 Nov 5;259:115664. doi: 10.1016/j.ejmech.2023.115664. Epub 2023 Jul 18. Eur J Med Chem. 2023. PMID: 37487306

9

The past, present and future of potential small-molecule drugs targeting p53-MDM2/MDMX for cancer therapy.

Liu Y, Wang X, Wang G, Yang Y, Yuan Y, Ouyang L. Liu Y, et al. Eur J Med Chem. 2019 Aug 15;176:92-104. doi: 10.1016/j.ejmech.2019.05.018. Epub 2019 May 8. Eur J Med Chem. 2019. PMID: 31100649 Review.

10

Discovery of Novel Potent and Fast BTK PROTACs for the Treatment of Osteoclasts-Related Inflammatory Diseases.

Huang J, Ma Z, Peng X, Yang Z, Wu Y, Zhong G, Ouyang T, Chen Z, Liu Y, Wang Q, Chen J, Chen T, Zeng Z. Huang J, et al. Among authors: liu y. J Med Chem. 2024 Feb 22;67(4):2438-2465. doi: 10.1021/acs.jmedchem.3c01414. Epub 2024 Feb 6. J Med Chem. 2024. PMID: 38321747

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209,791 results

Search Page

Filters